NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives $28.50 Consensus PT from Brokerages
Shares of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP – Get Free Report) have received an average rating of “Buy” from the five research firms that are presently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The […]
Shares of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP – Get Free Report) have received an average rating of “Buy” from the five research firms that are presently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The […]
